Allergan Prepares Takeover Bid for Shire

Apr 30, 2014


Allergan Inc., facing an unsolicited bid from Valeant Pharmaceuticals International Inc., is preparing to approach Shire Plc about a potential takeover, even though the Irish drugmaker rebuffed a previous overture, according to a Reuters article. A bid by Allergan for Shire, which has a market value of $32 billion, would show how determined the U.S. dermatology drugmaker is to stay independent. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments